RxDoctor Payments Data

Erma Benitez, MD

Dermatology · Los Angeles, CANPI 1972635282

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $963 of the $1,463 with a category attached, or 65.8%. 10 manufacturers reported payments, led by 3M Company at 34.2% of the total. Reporting peaked in 2019 at $1,141 and has fallen 90.4% since, to $110 in 2025. That places this record below the midpoint for dermatology clinicians in CA, where the typical reported total is $1,655.

$1,463in general payments, 2019–2025

Across 31 payments — averaging $47.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • 3M Company$500
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$293
  • Pfizer$196
  • Bristol Myers Squibb$142
  • Stemline Therapeutics Inc.$86
  • Incyte Corporation$79
  • plus $167 from 4 others

What the payments were for

  • Consulting fees$50034%
  • Food & beverage$96366%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,463 in reported general payments places this provider in the 45th percentile of 1,875 dermatology providers in California.

See all dermatology providers in California →

Medicare billing

Part B allowed, 2024
$11,127
Medicare patients
63
Services billed
102

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Calcipotriene11$2,579
Betamethasone Dipropionate26$1,175
Fluocinolone Acetonide13$484
Ketoconazole31$306
Triamcinolone Acetonide18$138

Paid to pharmacies, not to this prescriber.

Other dermatology in Los Angeles

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →